XOR-Labs Receives $2.6M to Advance Work in Improving the Quality of Donor Lungs
COPD, Cystic Fibrosis, Idiopathic Pulmonary Fibrosis, Lung Cancer, News
XENiOS, a German company specializing in medical devices for minimally invasive lung-and-heart assist, recently announced that it has invested $2.6 million in XOR-Labs Toronto, a spin-off with the potential to markedly improve the ... Read more